NASDAQ NMS - GLOBAL MARKET · ACON
+0.74% · +$0.0200 · Vol 44.4K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Aclarion Inc

Aclarion Inc

Health Care
$2.71
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
ACON
Aclarion Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ACON moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ACON catalysts
About Aclarion Inc
SERVICES-MEDICAL LABORATORIES
Listed since
2022
Employees
11
Country
US

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.75
Day high
$2.83
Day low
$2.58
Previous close
$2.69
52W high
$9.69
-72.03% from high
52W low
$2.02
9% of range
Market cap
$7.8M
EPS
$-8.1400
Beta
1.05
Shares out
2.9M
Volume
44.4K
0.80× rel vol
Avg volume
55.8K
VWAP
$2.71
Price history computed in-house
1W
-2.17%
1M
+11.98%
3M
-14.24%
1Y
-62.88%
YTD
-41.09%
SMA 50 $2.66 · above
SMA 200 $3.78 · below
52W position 9%

ACON overview

Veridion Score
59
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ACON.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ACON Form 4 filings
Public disclosures

Congress activity in ACON

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ACON in the cached public ledger.

Federal contracts

ACON contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ACON in this window.
Lobbying spend

ACON lobbying filings, year to date.

Registered lobbying filings matched to Aclarion Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ACON in this window.
Loading news for ACON
Analyst ratings
Sovereign unlock shows live analyst consensus for ACON.
Options
Sovereign unlock shows live options positioning for ACON.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.